Sanofi Pasteur turned down the government's demand for the French drug firm to refund the P3.5 billion that the Philippines had spent for the controversial anti-dengue vaccine Dengvaxia, which is currently being investigated in Congress.
Sanofi Pasteur thumbs down PH demand for P3.5-B Dengvaxia refund
Sanofi Pasteur turned down the government's demand for the French drug firm to refund the P3.5 billion that the Philippines had spent for the controversial anti-dengue vaccine Dengvaxia, which is currently being investigated in Congress.
Post a Comment